Targeting Raised von Willebrand Factor Levels in Liver Diseases: Opening Up Newer Therapeutic Avenues

Targeting Raised von Willebrand Factor Levels in Liver Diseases: Opening Up Newer Therapeutic Avenues

Raised levels of the blood coagulation protein von Willebrand factor (VWF) are now recognised to be important in patients with liver disease. The markedly raised plasma VWF levels in patients with acute liver failure and acute-on-chronic liver failure may contribute to the pathogenesis of liver fa...

Full description

Bibliographic Details
Main Authors: Ashish Goel, Sukesh C. Nair, Uday Zachariah, Kunissery A. Balasubramanian, Ian Mackie, Elwyn Elias
Format: Article
Language:English
Published: European Medical Journal 2020-04-01
Series:European Medical Journal Hepatology
Subjects:
liver failure
therapeutic plasma exchange
von willebrand factor (vwf) reduction
Online Access:https://www.emjreviews.com/hepatology/article/targetting-raised-von-willebrand-factor-levels-in-liver-diseases-opening-up-newer-therapeutic-avenues/

Internet

https://www.emjreviews.com/hepatology/article/targetting-raised-von-willebrand-factor-levels-in-liver-diseases-opening-up-newer-therapeutic-avenues/

Similar Items